Can a common antibiotic beat syphilis?
NCT ID NCT05548426
First seen Mar 16, 2026 · Last updated Jun 11, 2026 · Updated 17 times
Summary
This study tests whether the antibiotic linezolid can effectively treat early syphilis in 24 adults. Participants have primary, secondary, or early latent syphilis, and some also have well-controlled HIV. The main goal is to see if linezolid reduces syphilis infection markers in the blood within 6 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYPHILIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Howard Brown Health
Chicago, Illinois, 60613, United States
-
Open Arms HealthCare Center
Jackson, Mississippi, 39216, United States
-
Open Door Health
Providence, Rhode Island, 02907, United States
-
University of Mississippi Medical Center
Jackson, Mississippi, 39216, United States
-
Wake Forest Baptist Health
Greensboro, North Carolina, 27405, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.